{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:19:04Z","timestamp":1790054344935,"version":"4.0.1"},"reference-count":34,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2014,2,22]],"date-time":"2014-02-22T00:00:00Z","timestamp":1393027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Capital Medical Development Scientific Research Fund","award":["20091003"],"award-info":[{"award-number":["20091003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Cardiology"],"published-print":{"date-parts":[[2014,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Soluble suppression of tumorigenicity (\n                      <jats:styled-content style=\"fixed-case\">sST2<\/jats:styled-content>\n                      ) has been proposed to be a marker for biomechanical strain and a possible predictor of mortality in patients with chronic heart failure. The use of\n                      <jats:styled-content style=\"fixed-case\">sST2<\/jats:styled-content>\n                      in pulmonary arterial hypertension (\n                      <jats:styled-content style=\"fixed-case\">PAH<\/jats:styled-content>\n                      ) has not been well defined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>Plasma sST2 levels may correlate with the disease severity and predict clinical worsening in PAH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We performed a cohort study of 40 idiopathic\n                      <jats:styled-content style=\"fixed-case\">PAH<\/jats:styled-content>\n                      patients with data on demographics, exercise capacity, echocardiographic parameters, laboratory tests, hemodynamics, and medications. Plasma\n                      <jats:styled-content style=\"fixed-case\">sST2<\/jats:styled-content>\n                      was assessed with the high\u2010sensitivity\n                      <jats:styled-content style=\"fixed-case\">ST2 ELISA<\/jats:styled-content>\n                      kit at diagnostic catheterization. All patients were followed up from the date of blood sampling. The endpoint was clinical worsening.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">sST2<\/jats:styled-content>\n                      was significantly elevated in patients with idiopathic\n                      <jats:styled-content style=\"fixed-case\">PAH<\/jats:styled-content>\n                      compared with control subjects (28.9\u2009\u00b1\u200913.9 vs 20.7\u2009\u00b1\u20097.5\u2009ng\/\n                      <jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>\n                      ,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.003). Pearson correlation analysis revealed that\n                      <jats:styled-content style=\"fixed-case\">sST2<\/jats:styled-content>\n                      levels correlated with cardiac index (\n                      <jats:italic>r<\/jats:italic>\n                      = \u22120.534,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.000) and pulmonary vascular resistance (\n                      <jats:italic>r<\/jats:italic>\n                      = 0.350,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.027), and could reflect disease severity of\n                      <jats:styled-content style=\"fixed-case\">PAH<\/jats:styled-content>\n                      . After a mean follow\u2010up of 14\u2009\u00b1\u20095\u2009months, 12 patients showed clinical worsening. Receiver operating characteristic analysis suggested that\n                      <jats:styled-content style=\"fixed-case\">sST2<\/jats:styled-content>\n                      levels &gt;31.4\u2009ng\/\n                      <jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>\n                      discriminated clinical worsening with a sensitivity and specificity of 83.3% and 78.6%, respectively. Kaplan\u2010Meier analysis showed that higher\n                      <jats:styled-content style=\"fixed-case\">sST2<\/jats:styled-content>\n                      levels (&gt;31.4\u2009ng\/\n                      <jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>\n                      ) were associated with poor clinical outcomes (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.008). Multivariate Cox regression analysis showed that\n                      <jats:styled-content style=\"fixed-case\">sST2<\/jats:styled-content>\n                      was an independent predictor of clinical worsening (hazard ratio: 6.067, 95% confidence interval: 1.317\u201327.948,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.021).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">sST2<\/jats:styled-content>\n                      correlates with disease severity and is a significant predictor of clinical worsening in patients with\n                      <jats:styled-content style=\"fixed-case\">PAH<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/clc.22262","type":"journal-article","created":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T12:48:14Z","timestamp":1393246094000},"page":"365-370","source":"Crossref","is-referenced-by-count":51,"title":["Plasma Soluble\n                    <scp>ST2<\/scp>\n                    Levels Correlate With Disease Severity and Predict Clinical Worsening in Patients With Pulmonary Arterial Hypertension"],"prefix":"10.1002","volume":"37","author":[{"given":"Ya\u2010Guo","family":"Zheng","sequence":"first","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian\u2010Guo","family":"He","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi\u2010Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang\u2010Ming","family":"Xiong","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Gu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin\u2010Hai","family":"Ni","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi\u2010Hui","family":"Zhao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,2,22]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp297"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.20770"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22009"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000084544.54513.E2"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.8.865"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.2.9812078"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.4103\/2045-8932.109917"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22210"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30634"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2660"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000038705.69871.D9"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000127958.21003.5A"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.08.047"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2011.173369"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.110.958223"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.07.042"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.108.833707"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.06.033"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.2217\/bmm.13.116"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-13-1033"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.12.031"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1586\/erm.12.128"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.199661"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201105-0848OC"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.2.9811062"},{"key":"e_1_2_7_27_1","first-page":"2826","article-title":"Acute responses to inhalation of iloprost in patients with pulmonary hypertension","volume":"125","author":"Zhang HL","year":"2012","journal-title":"Chin Med J (Engl)."},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2009.08.010"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc11440"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2692"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0492"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.09.027"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.150953.5"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.150953.6"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1213917"}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.22262","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/clc.22262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T08:58:45Z","timestamp":1696323525000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.22262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,22]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1002\/clc.22262"],"URL":"https:\/\/doi.org\/10.1002\/clc.22262","archive":["Portico"],"relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"value":"0160-9289","type":"print"},{"value":"1932-8737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,22]]}}}